Engineers Gate Manager’s Adaptive Biotechnologies ADPT Stock Holding History

Engineers Gate Manager’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$799K	Buy	57,540 +35,944	+166%	+$573K	0.01%	1167
2025 Q4	$351K	Sell	21,596 -83,453	-79%	-$1.36M	﹤0.01%	1551
2025 Q3	$1.57M	Buy	+105,049	New	+$1.28M	0.02%	908
2024 Q4	–	Sell	-56,413	Closed	-$289K	–	2186
2024 Q3	$289K	Sell	56,413 -17,014	-23%	-$74.1K	0.01%	1637
2024 Q2	$266K	Buy	73,427 +43,406	+145%	+$138K	0.01%	1527
2024 Q1	$96.4K	Buy	+30,021	New	+$116K	﹤0.01%	1753
2023 Q3	–	Sell	-21,057	Closed	-$141K	–	1750
2023 Q2	$141K	Sell	21,057 -11,042	-34%	-$82.1K	0.01%	1526
2023 Q1	$283K	Buy	32,099 +8,879	+38%	+$78.3K	0.01%	1276
2022 Q4	$177K	Sell	23,220 -8,325	-26%	-$64.8K	0.01%	1408
2022 Q3	$225K	Buy	+31,545	New	+$297K	0.01%	1257

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Engineers Gate Manager's ADPT Position: Q1 2026 in Review

Engineers Gate Manager increased its Adaptive Biotechnologies (ADPT) stake by 166% in Q1 2026, buying an estimated $573K and bringing the position to 57,540 shares worth $799K. The position accounts for 0.01% of the portfolio, ranked #1167.

Engineers Gate Manager first reported a position in ADPT in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.57M in Q3 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Engineers Gate Manager held 57,540 shares of Adaptive Biotechnologies worth $799K as of Q1 2026.
Engineers Gate Manager bought 35,944 Adaptive Biotechnologies shares in Q1 2026, an estimated $573K.
Adaptive Biotechnologies made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1167 holding.
Engineers Gate Manager first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 10 quarters since.
Engineers Gate Manager's Adaptive Biotechnologies position peaked at $1.57M in Q3 2025.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.